LEMKEY JOHN G (Chief Financial Officer) received a stock award from ODONATE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/3/2020ACC: 0001209191-20-056583
Officer· Chief Financial Officer
Since Jun 2018
+192.00
Net shares
Net buyer
$1.2K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
192.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+96.00
Price / share
$12.25
Trade value
$1.18K
% of position
3.0%
10/30/2020
3.25K→3.35K
Total
Net shares
+96.00
Net value
$1.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/30/2020 | A · Award | +96.00 | $12.25 | $1.18K | 3.0% | 3.25K | 3.35K |
| Total | +96.00 | $1.18K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
96.00 shares
Shares
+96.00
Strike price
14.41
Held after
96.00
Exercisable
—
10/30/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock96.00 shares | 10/30/2020 | A · Award | +96.00 | 14.41 | — | 96.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned15.24M
Total
15.24M indirect15.24M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 15.24M | Indirect |
| Total | 15.24M | 15.24M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported